Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (28)

2023

  1. Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic

    Viruses, Vol. 15, Núm. 2

  2. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

  3. Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

    Viruses, Vol. 15, Núm. 4

2022

  1. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial

    JAMA Network Open, Vol. 5, Núm. 1

2021

  1. Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality

    Mediators of Inflammation, Vol. 2021

2019

  1. Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

    Microbial Pathogenesis, Vol. 128, pp. 112-118

2018

  1. Clinical predictors of candidemia in medical non-neutropenic, non-ICU patients. The CaMed score

    International Journal of Clinical Practice, Vol. 72, Núm. 12

  2. Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapy

    HIV Clinical Trials, Vol. 19, Núm. 5, pp. 197-201

  3. Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain"

    Antimicrobial agents and chemotherapy

2017

  1. Genomics and susceptibility profiles of extensively drug-resistant pseudomonas aeruginosa isolates from Spain

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 11

  2. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109

2016

  1. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8

2015

  1. Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 1, pp. 40.e1-40.e16

  2. Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 1, pp. 41-47

  3. Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis

    Infection, Vol. 43, Núm. 5, pp. 531-535

2014

  1. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals

    Clinical Microbiology and Infection, Vol. 20, Núm. 4, pp. 361-367

2011

  1. Complications detection in treatment for bacterial endocarditis

    Advances in Intelligent and Soft Computing

  2. Genetic algorithms to simplify prognosis of endocarditis

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

2010

  1. C-reactive protein for discriminating treatment failure from slow responding pneumonia

    European Journal of Internal Medicine, Vol. 21, Núm. 6, pp. 548-552

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092